Dr Eric Berg DC has warned suffering from the condition every night could put you more at risk of several chronic diseases ...

In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...

The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi, nearly ...

Dr Eric Berg DC has shared 'hidden dangers' and numerous health risks of the problem that affects many at night ...

AbbVie Inc.'s stock rose 4% early Friday, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth needed to ...

Going out to restaurants, playing bingo, visiting friends, or attending religious services could give you extra years of healthy brain function, according to new research from Rush University Medical ...

Clinical trials have demonstrated that the drug can delay deterioration by four to six months, targeting the beta-amyloid protein in the brain. Another medication, donanemab, has received approval but ...

Guess its time to time to start huffing Vicks VapoRub - scientists just discovered that menthol might help keep your brain from turning into Swiss cheese. Researchers at Spain's Center for Applied ...

European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for ...

Despite the regulatory setback, BioArctic's partner Eisai has stated that the safety profile of lecanemab reported in clinical practice in the United States, Japan, and other countries is consistent ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee for Medicinal Products for Human Use (CHMP) to consider two ...